Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

226
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

420
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
420
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

116
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

236
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
236
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

834
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
834
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Scoping Review of Interventions to Prevent Lost Surgical Specimens in the Preanalytical Phase.

AORN journal·2026
Same author

Writing for the AORN Journal: Supporting Elements Really Do Support Your Manuscript.

AORN journal·2025
Same author

The brushstrokes of scholarship: Special emphasis on writing with references.

Journal of the American Association of Nurse Practitioners·2025
Same author

The Eloquence of Appropriate Citation Practices.

AORN journal·2025
Same author

Tips for writing effective abstracts.

Journal of the American Association of Nurse Practitioners·2025
Same author

The importance of knowing what your nursing credentials mean.

Journal of the American Association of Nurse Practitioners·2025
Same journal

Guideline Quick View: Environmental Hygiene.

AORN journal·2026
Same journal

Air Quality as a Cornerstone of Sterile Technique.

AORN journal·2026
Same journal

Brief Limb-Focused Prewarming in Adults Undergoing General Anesthesia: A Randomized Trial.

AORN journal·2026
Same journal

Clinical Issues - July 2026.

AORN journal·2026
Same journal

The Power of Learning From Mishaps and Missteps.

AORN journal·2026
Same journal

Embracing the Future of Care.

AORN journal·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Formation of Dispersible Taohong Siwu Tablets
05:44

Formation of Dispersible Taohong Siwu Tablets

Published on: February 3, 2023

2.4K

Understanding medication compounding issues.

Rodney W Hicks

    AORN Journal
    |March 29, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Perioperative nurses must understand sterile compounding guidelines to prevent contamination and infections from immediate use products. Key factors include quality control, a controlled environment, proper personnel practices, and process monitoring for patient safety.

    Keywords:
    compoundingcontaminationimmediate use productsmedication compoundingperioperative practice standards

    More Related Videos

    Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
    07:00

    Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

    Published on: August 11, 2017

    7.9K
    Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
    11:17

    Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

    Published on: August 30, 2018

    11.6K

    Related Experiment Videos

    Last Updated: May 1, 2026

    Formation of Dispersible Taohong Siwu Tablets
    05:44

    Formation of Dispersible Taohong Siwu Tablets

    Published on: February 3, 2023

    2.4K
    Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
    07:00

    Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

    Published on: August 11, 2017

    7.9K
    Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
    11:17

    Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

    Published on: August 30, 2018

    11.6K

    Area of Science:

    • Pharmacy
    • Nursing
    • Infection Control

    Background:

    • Contamination of compounded products poses a significant risk to patient safety, leading to potential infections.
    • Immediate use products are common in perioperative settings, necessitating specialized knowledge for nurses.

    Purpose of the Study:

    • To educate perioperative nurses on guidelines and practices for sterile compounding.
    • To highlight critical factors in reducing contamination during the sterile compounding process.

    Main Methods:

    • Review of common themes contributing to successful sterile compounding.
    • Emphasis on quality, environment, personnel activities, and control processes.

    Main Results:

    • Successful compounding relies on four key themes: quality, environment, personnel activities, and control processes.
    • Specific practices include product identification, purity, stability, segregated compounding areas, hand hygiene, and process monitoring.

    Conclusions:

    • Perioperative nurses must be knowledgeable about sterile compounding to ensure patient safety.
    • Awareness of vendor responsibilities is crucial when third-party compounding services are utilized.